Douglas K. Marks

Quantitative Analysis of Immune Infiltrates in Primary Melanoma

Robyn D. Gartrell, Douglas K. Marks, Thomas D. Hart et al. · Cancer Immunology Research · 2018 · 136 citations · Full text

Medicine, Oncology, Pathology +17

Electrocautery Ablation of High-Grade Anal Squamous Intraepithelial Lesions in HIV-Negative and HIV-Positive Men Who Have Sex With Men

Douglas K. Marks, Stephen E. Goldstone · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2011 · 76 citations

Medicine, Pathology, Surgery +12

First-in-human phase 1/2a study of a potent and novel CDK2-selective inhibitor PF-07104091 in patients (pts) with advanced solid tumors, enriched for CDK4/6 inhibitor resistant HR+/HER2- breast cancer.

Timothy A. Yap, Abdelaziz M. Elhaddad, Rachel N. Grisham et al. · Journal of Clinical Oncology · 2023 · 56 citations

Medicine, Pharmacology, Pharmacotherapy +14

Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibition

Zoë Blake, Douglas K. Marks, Robyn D. Gartrell et al. · Journal for ImmunoTherapy of Cancer · 2018 · 43 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma

Robyn D. Gartrell, Andrew Chen, Emanuelle M. Rizk et al. · Cancer Research · 2020 · 31 citations · Full text

Medicine, Immunology, Oncology +17